Security key
92764N102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 115,546,439
- Total 13F value
- $696,533,329
- Share change
- -1,210,173
- Put/Call ratio
- 26%
- SEC-reported price per share
- $6.03
- Number of holders
- 218
- Value change
- -$6,968,165
- Number of buys
- 88
- Number of sells
- 107
- Shares outstanding
- 168,677,036
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
218
Top holders
10
VIR full security history
Ownership snapshot
Full 13F holder table
Vir Biotechnology, Inc. SEC filings
Vir Biotechnology, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of VIR - Vir Biotechnology, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
01 Dec 2025
13D/G
13F
3/4/5
Lead comparable stake: 11%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
11%
SVF Endurance (Cayman) Ltd
8.1%
SB INVESTMENT ADVISERS (UK) LTD
9.9%
ARCH Venture Management, LLC
7.7%
VANGUARD GROUP INC
7.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
11%
|
$93,255,785
14,826,039 shares
|
$0 | 31 Mar 2025 |
| SVF Endurance (Cayman) Ltd |
3/4/5
10%+ Owner
|
8.1%
|
$82,134,660
13,728,924 shares
|
-$17,847,707 | 01 Dec 2025 |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
9.9%
|
$95,265,874
16,684,041 shares
|
— | 30 Sep 2025 |
| ARCH Venture Management, LLC |
13F
Company
|
7.7%
|
$73,754,146
12,916,663 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
7.6%
|
$73,084,465
12,799,381 shares
|
— | 30 Sep 2025 |
| STATE STREET CORP |
13F
Company
|
3.1%
|
$29,927,783
5,241,293 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
218
Shares
115,546,439
Rows available
218
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
209
Q4 2025 holders
218
Holder diff
9
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|